Article
Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer.
Mayo Clinic proceedings - 1 Jan 2002
Kantarci Orhun H, Lesnick Timothy G, Yang Ping, Meyer Rebecca L, Hebrink David D, McMurray Cynthia T, Weinshenker Brian G
Abstract excerpt
OBJECTIVE: To study the association of the myeloperoxidase (MPO) -463 (G-->A) polymorphism with lung cancer risk. PATIENTS AND METHODS: We performed a paired case-control analysis of 307 patients with primary lung cancer and an equal number of age-, sex-, and ethnicity-matched controls to evaluate the effect of the MPO -463 (G-->4A) polymorphism on disease susceptibility. We also performed conditional logistic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
